2016 Annual Meeting | REM Sleep Behavior Disorder

Date Sunday 04/17/16

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Alon Y. Avidan, MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should be able to improve participants’ confidence in recognizing the presenting signs and symptoms of REM sleep behavior disorder; use the patient perspective to become better equipped with strategies for improved recognition of the impact of RBD, becoming aware with an initial attempt to cope with aggressive dream enactment to successful amelioration of the episodes with specific therapy; use the case presentation to enhance competency in RBD diagnostic criteria, differential diagnosis, pathophysiology, and evidence based therapy, especially with respect to safety intervention and prognostic implication; describe the prognostic value of RBD, discuss the condition with patients and family members, and disclose its implication in a supportive manner.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 AM - 07:15 AM		REM Sleep Behavior Disorder: Patient Interview, Clinical Features, Diagnosis, and Treatment Alon Y. Avidan, MD, MPH, FAAN
07:15 AM - 08:00 AM		Pathophysiology & Current Understanding of RBD Bradley F. Boeve, MD, FAAN
08:00 AM - 08:30 AM		Discussion and Question & Answer Session

Faculty Disclosures
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Alon Y. Avidan, MD, MPH, FAAN	Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��